What Are the Predictors for Achieving Therapeutic Levetiracetam Serum Concentrations in Adult Neurological Patients?

Cotta, Menino O; Abdul-Aziz, Mohd H; Frey, Otto R; Sime, Fekade B; Roberts, Jason A; Roehr, Anka C

Cotta, Menino O; Abdul-Aziz, Mohd H; Frey, Otto R; Sime, Fekade B; Roberts, Jason A; Roehr, Anka C.

Afiliação

Cotta MO; Faculty of Medicine, University of Queensland Centre for Clinical Research, the University of Queensland, Brisbane, Australia.
Abdul-Aziz MH; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, the University of Queensland, Brisbane, Australia.
Frey OR; Faculty of Medicine, University of Queensland Centre for Clinical Research, the University of Queensland, Brisbane, Australia.
Sime FB; Department of Pharmacy, General Hospital of Heidenheim, Schlosshaustraße, Heidenheim, Germany; and.
Roberts JA; Faculty of Medicine, University of Queensland Centre for Clinical Research, the University of Queensland, Brisbane, Australia.
Roehr AC; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, the University of Queensland, Brisbane, Australia.

Ther Drug Monit ; 42(4): 626-630, 2020 08.

Article em En | MEDLINE | ID: mdl-31977751

Assuntos

Anticonvulsivantes/sangue; Levetiracetam/sangue; Idoso; Idoso de 80 Anos ou mais; Anticonvulsivantes/uso terapêutico; Estado Terminal; Feminino; Humanos; Levetiracetam/uso terapêutico; Masculino; Pessoa de Meia-Idade; Gravidez; Estudos Retrospectivos; Convulsões/sangue; Convulsões/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levetiracetam / Anticonvulsivantes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google